Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient

BACKGROUND: Sézary syndrome (SS) is a rare lymphoproliferative neoplasm, almost incurable outside the setting of allogeneic transplantable patients. The prognosis for relapsed/refractory patients remains poor, as the available drugs confer short-lasting remission. In this setting, the anti-chemokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lolli, Ginevra, Casadei, Beatrice, Argnani, Lisa, Nanni, Laura, Cavo, Michele, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340218/
https://www.ncbi.nlm.nih.gov/pubmed/32670518
http://dx.doi.org/10.4084/MJHID.2020.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340218/
https://www.ncbi.nlm.nih.gov/pubmed/32670518
http://dx.doi.org/10.4084/MJHID.2020.040

Ejemplares similares